Countries Europe
Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...
March 30, 2023 | News
Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...
March 29, 2023 | Influencers
▪ Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards&nbs...
March 28, 2023 | News
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial resistance, today announces that it ...
March 28, 2023 | News
The aim of the Pathology Innovation Incubator, founded by Epredia and 3DHISTECH, is to develop and improve solutions that revolutionize tumor diagnostics a...
March 27, 2023 | News
The STEDYCON™ STED microscope is a super-resolution fluorescence microscope, which allows researchers to visualize biological structures and processe...
March 27, 2023 | News
Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product por...
March 27, 2023 | News
Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuri...
March 27, 2023 | News
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovatio...
March 22, 2023 | News
Two top 10 pharma companies are seeking to trial Optimer-Fc for IHC Aptamer is currently working with one of the top three IHC companies to validate the...
March 21, 2023 | News
Lunit set to launch Lunit INSIGHT DBT in the European market Lunit seeks FDA clearance, paving the way into the US market The MDR CE certification is...
March 21, 2023 | News
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...
March 20, 2023 | News
Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...
March 20, 2023 | News
Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Ins...
March 09, 2023 | News
Most Read
Bio Jobs
News
Editor Picks